ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 150 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 2 | -89.5% | 0.00% | – |
| Q1 2017 | $1,000 | -99.7% | 19 | -99.8% | 0.00% | -100.0% |
| Q4 2016 | $294,000 | +19.0% | 8,783 | -5.5% | 0.00% | 0.0% |
| Q3 2016 | $247,000 | -28.4% | 9,290 | -40.7% | 0.00% | 0.0% |
| Q2 2016 | $345,000 | -31.1% | 15,655 | -8.2% | 0.00% | -50.0% |
| Q1 2016 | $501,000 | -2.1% | 17,053 | +10.1% | 0.00% | 0.0% |
| Q4 2015 | $512,000 | +7.1% | 15,491 | +17.2% | 0.00% | 0.0% |
| Q3 2015 | $478,000 | 0.0% | 13,221 | +24.5% | 0.00% | 0.0% |
| Q2 2015 | $478,000 | +102.5% | 10,622 | +38.0% | 0.00% | +100.0% |
| Q1 2015 | $236,000 | – | 7,698 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 858,811 | $36,156,000 | 10.56% |
| Fairmount Funds Management LLC | 150,433 | $6,333,000 | 2.26% |
| ARMISTICE CAPITAL, LLC | 1,356,000 | $57,088,000 | 1.94% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,775,000 | $74,728,000 | 0.45% |
| Virtus ETF Advisers LLC | 14,321 | $603,000 | 0.25% |
| Granahan Investment Management | 231,071 | $9,728,000 | 0.22% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 248,320 | $10,454,000 | 0.09% |
| ACADIAN ASSET MANAGEMENT LLC | 467,514 | $19,684,000 | 0.08% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 126 | $5,000 | 0.08% |
| AIGEN INVESTMENT MANAGEMENT, LP | 12,854 | $541,000 | 0.07% |